What exactly happened in the Feb 18, 2026 IDYA analyst rating update?

On **February 18, 2026** Cantor Fitzgerald reiterated an **Overweight** rating on IDEAYA (IDYA). The action was a maintenance, not an upgrade or downgrade, and the published note did not include a new price target.

Does a maintained Overweight mean I should buy IDYA now?

A maintained Overweight means Cantor Fitzgerald expects IDYA to outperform peers. It is not a direct buy signal. Combine the IDYA analyst rating with pipeline updates, financials, and your risk tolerance before trading.

Was a new IDYA price target issued with the maintained rating?

No. Cantor Fitzgerald reiterated Overweight on **February 18, 2026** without a new IDYA price target. Investors should watch for later reports or conference remarks for updated targets.

How does Meyka AI view this IDYA analyst rating?

Meyka AI notes the maintained Overweight as a vote of confidence in relative performance. Meyka AI rates IDYA with a grade of **B**, based on benchmarks, sector results, growth metrics, and analyst consensus.

Analyst Ratings

Cantor Fitzgerald Maintains Overweight on IDEAYA (IDYA) Feb 18, 2026

ByHuzaifa Zahoor February 19, 2026

Cantor Fitzgerald maintained an Overweight rating on IDEAYA Biosciences, Inc. (IDYA) on February 18, 2026. This note is the latest IDYA analyst rating and signals the firm expects IDYA to outperform peers. Cantor Fitzgerald did not list a new price target in the published note, and the stock showed a modest move of -0.53% ($-0.16) after the release. The action is a maintenance, not an upgrade or downgrade, and keeps analyst sentiment steady for IDYA.